NM_021922.3:c.1095A>C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_021922.3(FANCE):āc.1095A>Cā(p.Arg365Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,614,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_021922.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000526 AC: 80AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000155 AC: 39AN: 251488Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135920
GnomAD4 exome AF: 0.0000636 AC: 93AN: 1461880Hom.: 0 Cov.: 32 AF XY: 0.0000481 AC XY: 35AN XY: 727236
GnomAD4 genome AF: 0.000525 AC: 80AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.000484 AC XY: 36AN XY: 74436
ClinVar
Submissions by phenotype
Fanconi anemia complementation group E Uncertain:1Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
- -
not specified Uncertain:1Other:1
- -
DNA sequence analysis of the FANCE gene demonstrated a sequence change, c.1095A>C, in exon 5 that results in an amino acid change, p.Arg365Ser. This sequence change does not appear to have been previously described in individuals with FANCE-related disorders. This sequence change has been described in the gnomAD database with a frequency of 0.23% in the African American/African subpopulation (dbSNP rs141268133). The p.Arg365Ser change affects a poorly conserved amino acid residue located in a domain of the FANCE protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Arg365Ser substitution. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Arg365Ser change remains unknown at this time. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at